Suppr超能文献

美国 COVID-19 大流行期间的心血管死亡病例。

Cardiovascular Deaths During the COVID-19 Pandemic in the United States.

机构信息

Richard and Susan Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical and Harvard Medical School, Boston, Massachusetts, USA.

Richard and Susan Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical and Harvard Medical School, Boston, Massachusetts, USA.

出版信息

J Am Coll Cardiol. 2021 Jan 19;77(2):159-169. doi: 10.1016/j.jacc.2020.10.055.

Abstract

BACKGROUND

Although the direct toll of COVID-19 in the United States has been substantial, concerns have also arisen about the indirect effects of the pandemic. Hospitalizations for acute cardiovascular conditions have declined, raising concern that patients may be avoiding hospitals because of fear of contracting severe acute respiratory syndrome- coronavirus-2 (SARS-CoV-2). Other factors, including strain on health care systems, may also have had an indirect toll.

OBJECTIVES

This investigation aimed to evaluate whether population-level deaths due to cardiovascular causes increased during the COVID-19 pandemic.

METHODS

The authors conducted an observational cohort study using data from the National Center for Health Statistics to evaluate the rate of deaths due to cardiovascular causes after the onset of the pandemic in the United States, from March 18, 2020, to June 2, 2020, relative to the period immediately preceding the pandemic (January 1, 2020 to March 17, 2020). Changes in deaths were compared with the same periods in the previous year.

RESULTS

There were 397,042 cardiovascular deaths from January 1, 2020, to June 2, 2020. Deaths caused by ischemic heart disease increased nationally after the onset of the pandemic in 2020, compared with changes over the same period in 2019 (ratio of the relative change in deaths per 100,000 in 2020 vs. 2019: 1.11, 95% confidence interval: 1.04 to 1.18). An increase was also observed for deaths caused by hypertensive disease (1.17, 95% confidence interval: 1.09 to 1.26), but not for heart failure, cerebrovascular disease, or other diseases of the circulatory system. New York City experienced a large relative increase in deaths caused by ischemic heart disease (2.39, 95% confidence interval: 1.39 to 4.09) and hypertensive diseases (2.64, 95% confidence interval: 1.52 to 4.56) during the pandemic. More modest increases in deaths caused by these conditions occurred in the remainder of New York State, New Jersey, Michigan, and Illinois but not in Massachusetts or Louisiana.

CONCLUSIONS

There was an increase in deaths caused by ischemic heart disease and hypertensive diseases in some regions of the United States during the initial phase of the COVID-19 pandemic. These findings suggest that the pandemic may have had an indirect toll on patients with cardiovascular disease.

摘要

背景

尽管 COVID-19 在美国造成的直接损失相当大,但人们也对大流行的间接影响表示担忧。急性心血管疾病的住院率下降,这让人担心患者可能因为害怕感染严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)而避免去医院。其他因素,包括医疗系统的压力,也可能造成间接影响。

目的

本研究旨在评估 COVID-19 大流行期间是否因心血管疾病导致的人群死亡人数增加。

方法

作者使用美国国家卫生统计中心的数据进行了一项观察性队列研究,以评估 2020 年 3 月 18 日至 6 月 2 日美国大流行期间,与大流行前同期(2020 年 1 月 1 日至 3 月 17 日)相比,心血管疾病导致的死亡率。将死亡率的变化与前一年同期进行比较。

结果

2020 年 1 月 1 日至 6 月 2 日,共有 397042 例心血管疾病死亡。与 2019 年同期相比,2020 年大流行开始后,全国因缺血性心脏病导致的死亡人数增加(相对变化率:每 10 万人死亡人数增加 1.11,95%置信区间:1.04 至 1.18)。高血压病导致的死亡人数也有所增加(1.17,95%置信区间:1.09 至 1.26),但心力衰竭、脑血管病或其他循环系统疾病则没有增加。纽约市因缺血性心脏病(2.39,95%置信区间:1.39 至 4.09)和高血压病(2.64,95%置信区间:1.52 至 4.56)导致的死亡人数相对大幅增加。在纽约州其余地区、新泽西州、密歇根州和伊利诺伊州,这些疾病导致的死亡人数也略有增加,但在马萨诸塞州和路易斯安那州则没有增加。

结论

在美国的一些地区,COVID-19 大流行的初始阶段,缺血性心脏病和高血压病导致的死亡人数有所增加。这些发现表明,大流行可能对心血管疾病患者造成了间接影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc5/7800141/880370984c4e/fx1_lrg.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验